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1 |  INTRODUCTION
A 6-month old male entire Pug dog with a 2-month history 
of ataxia was referred to Fitzpatrick Referrals Neurology 
service for further investigations. On presentation, the dog's 
mentation was normal; he showed ambulatory tetraparesis 
and proprioceptive ataxia. Overreaching or floating thoracic 
limb gait was noted (Video S1) with a tendency for toenail 
scuffing and evidence of skin abrasions on the dorsal sur-
face of the feet, mainly of his left thoracic limb. Postural re-
actions were reduced in all limbs, with his left side being 
slightly worse. Spinal reflexes were intact, and cranial nerve 
assessment was unremarkable. There was no evidence of dis-
comfort, and no treatment was prescribed by his veterinarian 
prior referral. The dog showed a concurrent and mild brachy-
cephalic obstructive airway syndrome (BOAS). The neuro-
anatomic localization was determined to be C1-C5 spinal 
cord segments.
A complete blood cell count, serum biochemistry, and 
electrolytes were performed and were unremarkable.
2 |  CASE SUMMARY
Magnetic resonance (MR) images of the brain and cervical 
spine were acquired under general anesthesia using a 1.5 T 
scanner (Tim system, Siemens). The dog was positioned 
head first in dorsal recumbency on the scanning table, and 
MR data were obtained using a combination of the spine, 
neck, and body and spinal coils.
The brain protocol included T2-weighted (T2W; 
TR  =  3590  ms, TE 109  ms, FOV 105  ×  140, thick-
ness = 3.0 mm, spacing = 0.6 mm, matrix = 239 × 384 and 
NEX 2) and T1-weighted (T1W; TR = 515 ms, TE 14 ms, 
FOV 112 × 140, thickness = 3.0 mm, spacing = 0.6 mm, ma-
trix = 192 × 320 and NEX 3) in transverse planes.
The spinal protocol included T2W in sagittal (T2W; 
TR  =  4000  ms, TE 105  ms, FOV 220  ×  220, thick-
ness = 1.5 mm, spacing = 0.3 mm, matrix = 358 × 448 and 
NEX 4) and transverse planes (T2W; TR  =  3480  ms, TE 
101 ms, FOV 91 × 140, thickness = 3 mm, spacing = 0.3 mm, 
matrix  =  164  ×  384 and NEX 5), STIR in dorsal plane 
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Abstract
We report persistence of associated syringomyelia and formation of newly caudal 
spinal arachnoid diverticulum, following marsupialization surgery. We describe sy-
ringopleural shunt placement as a novel approach to treat both conditions in a Pug 
dog.
K E Y W O R D S
computed tomography, corticosteroid, laminectomy, magnetic resonance imaging, myelopathy, 
tetraparesis
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(STIR; TR = 3200 ms, TE 50 ms, FOV 160 × 270, thick-
ness  =  3  mm, spacing  =  0.6  mm, matrix  =  148  ×  384 
and NEX 2), and 3D-CISS sequence in transverse plane 
(3D-CISS; TR  =  11.72  ms, TE 5.86  ms, FOV 93  ×  150, 
thickness = 1.0 mm, spacing = 0.2 mm, matrix = 160 × 256 
and NEX 1). With the aid of the multiplanar reconstruction 
software integrated to the MRI scanner, 3D-CISS data were 
further processed in sagittal and dorsal planes.
Computed tomography of the head, neck, and thorax 
was performed under general anesthesia to evaluate the cor-
rect shunt placement (Aquilion PRIME, Toshiba Medical 
Systems, 160-slice multislice CT scanner). The dog was posi-
tioned head first in sternal recumbency on the scanning table, 
and images were acquired using a helical scan with 0.5-mm 
slice thickness and reconstructed in bone and soft tissue algo-
rithms as 2.0-mm transverse images and 0.5-mm multiplanar 
images (120 kV, 34-65 mAs, 240 mm FOV).
The MR images of the brain showed a mild ventricu-
lomegaly and a supracollicular fluid accumulation, which 
were considered nonclinically significant.1,2 The MR im-
ages of the cervical spinal cord showed the presence of a 
dorsal intradural-extramedullary cavity filled with CSF 
supporting the presence of a spinal arachnoid diverticulum 
(SAD) (L8mm  ×  H2mm  ×  W6mm) at the level of C2-C3 
intervertebral disc (IVD) space with secondary spinal cord 
compression. An hyperintense on T2WI and 3D-CISS and 
hypointense on T1WI structure compatible with syringomy-
elia (SM) (L7.3mm × H3.3mm × W3mm) were present cen-
trally and within the dorsal half of the spinal cord, just caudal 
to the SAD (Figure  1). Central canal dilation (transverse 
diameter: 1.2 mm) was present over the length of the C2 ver-
tebra, while an intramedullary hyperintensity on T2WI and 
isointensity on T1WI area compatible with spinal cord edema 
were visible over C4-C5 vertebrae.
The MR findings supported the presence of SAD, while 
SM was considered secondary to SAD due to cerebrospinal 
fluid (CSF) flow obstruction. The dog underwent surgery to 
address SAD via left dorsolateral laminectomy at the level 
of C2-C3 IVD space. A surgical scalpel blade no. 11 with 
bevel pointing upward was used to perform a small durotomy 
through which 45° angled microscissors were placed to ex-
tend the durotomy, followed by marsupialization of the diver-
ticulum using 6-0 Vicryl™ (Ethicon™) absorbable braided 
suture, anchoring the dural margins to the surrounding ep-
axial muscles. The dog received anti-inflammatory dose of 
prednisolone (Table  1) perioperatively to reduce the spinal 
cord edema. Multimodal analgesia with methadone at the 
dose of 0.2 mg/Kg IV every 4-6 hours (Comfortan™ 10 mg/
mL, Dechra) and paracetamol at the dose of 10 mg/Kg PO 
twice daily (Paracetamol suspension 120 mg/5 mL, McNeil) 
was also provided over the postoperative period.
The dog underwent physiotherapy in order to support his 
recovery. Prednisolone was restarted approximately 3 weeks 
after surgery, as signs of ataxia and stumbling of his thoracic 
limbs worsened. The neurological deficits appeared to be 
slightly worse on his right side. The dog showed a slight ame-
lioration of his clinical signs while receiving corticosteroids.
MRI of the cervical spine was performed at 2 (Figure 2A-
C) and 6 months (Figure 2D-F) postsurgery and revealed the 
resolution of the previous SAD; however, a newly formed 
F I G U R E  1  Magnetic resonance 
images; mid-sagittal T2W (A), 3D-CISS 
(B), and transverse 3D-CISS (C and 
D) images at the level of the C2-C3 
intervertebral disc space showing the 
presence of spinal arachnoid diverticulum 
(SAD) (blue dashed line and arrow) and 
syringomyelia (SM) (pink dashed line and 
arrow)
(A) (B)
(C) (D)
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CSF-filled structure (L9.5mm  ×  H2.5mm  ×  W3mm) was 
found dorsally to the SM and caudally to the surgical site. 
Spinal cord edema progressively worsened, extending over 
C4-C6 and over C4-C7 vertebrae at 2 months and 6 months 
postsurgery, respectively. Further neurological deteriora-
tion was reported, with increased thoracic limb paresis and 
T A B L E  1  Timeline of the clinical signs, imaging performed, and corticosteroid therapy
Timeline Age
Prednisolone 
therapy Comments
First manifestation of 
neurological signs
4 mo    
First referral consult& MRI & 
marsupialization
6 mo Perioperative. Diagnosis of SAD and SM was made.
0.3 mg/Kg SID for 7 d, 0.15 mg/kg SID for 10 d, and 0.15 mg/
kg EOD.
Restarted 
approx. 3 wk 
postsurgery.
The dog improved at the discharge but worsened a week after 
discontinuation of prednisolone, showing increased scuffing on 
thoracic limbs and falling onto his right side. Amelioration was 
reported after initiation of corticosteroids at 0.3mg/Kg SID.
2nd MRI (2 mo postsurgery) 8 mo Continued. SAD resolved, but SM was still present. Spinal cord edema 
increased, extending over C4-C6 vertebrae. Newly formed SAD 
noted caudal to the previous surgical site. Shunt kit was ordered.
10 d post-MRI Dose increased. Scuffing and bleeding from dorsal aspect of front paws. Increased 
corticosteroids to 0.4 mg/kg SID.
2 wk post-MRI Continued but 
dose slightly 
reduced.
Failed to improve with medical therapy and worsening of 
thoracic limb paresis with tendency for toenail scuffing. 
Reported possible sign of hyperaesthesia related to SM (ie, 
licking at his paws).
Gabapentin added at 15 mg/kg BID. Corticosteroid dose was 
slowly tapered down, but not able to lower below 0.3 mg/Kg 
SID, without deterioration.
3rd MRI (6 mo postsurgery) 1 y Continued. SAD and SM remained unchanged, although spinal cord edema 
increased extending over C4-C7 vertebrae.
Shunt surgery 1 y 2 mo Continued. Prior surgery, rubbing face on furniture indicating hyperesthesia: 
increased gabapentin to TID. The dog showed amelioration of 
signs.
Recheck 1 y 4 mo Continued. Ataxia and postural reactions have improved with his right 
thoracic limb remaining slightly paretic; hypermetria on thoracic 
limbs was still present.
Recheck &CT & revision surgery 1 y 5 mo Continued. Worsening of ataxia with knuckling and falling over onto his 
right side. On CT, distal shunt catheter dislodged. Shunt revision 
performed.
Recheck 1 y 6 mo Continued. Remained stable with no overall improvement. Starting to use 
quad wheelchair as aid to ambulate.
4th MRI (6-mo after shunt 
surgery)
1 y 8 mo Continued. On MRI, resolution of previous SAD and SM, but newly formed 
SAD noted. Mild spinal cord edema over C4 vertebra.
Neurologically stable with mild knuckling on his right thoracic 
limb.
2-2.5 y Reduced. Recurrence of face rubbing and left pelvic limb tremors was 
reported; signs resolved when gabapentin was restarted at 
15 mg/kg BID for a week. Gradually reduced steroids to 
0.15 mg/kg EOD.
Phone call update (2 y postshunt 
surgery)
3 y 2 mo Off. Off steroids. Reported recurrence of licking paw and rubbing 
face which resolved with hydrotherapy. Slight thoracic limb 
hypermetria and ataxia present, but overall stronger on all limbs.
Abbreviations: BID, twice daily; CT, computed tomography; EOD, every other day; MRI, magnetic resonance imaging; SAD, spinal arachnoid diverticulum; SID, 
once daily; SM, syringomyelia; TID, three times daily.
   | 1145TAURO And RUSBRIdGE
tendency for toenail scuffing causing skin excoriation on the 
dorsal surface of the feet. Signs of possible hyperaesthesia 
secondary to SM (ie, licking at his paws) were also present.3 
Prednisolone was increased to approx. 0.4 mg/Kg once daily, 
and gabapentin was started at the dose of 15 mg/Kg twice 
daily. Prednisolone was tapered to 0.3 mg/Kg once daily, as 
lower dose caused further deterioration. Prior to shunt sur-
gery, the dog started to rub his face on furniture (ie, hyperes-
thesia). Gabapentin was increased from twice to three times 
daily, and the signs appear to subside. A syringopleural shunt 
was placed approximately 6 months after the newly formed 
SAD was diagnosed, due to the delay of delivery of the shunt 
kit. Surgical approach at the level of the C2-C3 IVD space 
was performed, and the previous laminectomy site was iden-
tified: Laminectomy membrane was not present; however, 
scar tissue was found adhering to the dura mater. An attempt 
to remove this was made but abandoned, due to the multi-
ple attachments and the unlikeliness of success. Dorsal lam-
inectomy was extended caudally over C3 vertebra until the 
newly CSF-filled structure was identified by bluish discol-
oration of the dura mater. The perforated, open-ended prox-
imal tip of the catheter was trimmed to match the length of 
the CSF-filled cavity (approximately 0.5 mm) based on CT 
measurement and angled-cut for easy insertion. A limited 
durotomy, so that the shunt catheter will just pass through 
the opening, was performed using a surgical scalpel blade 
no. 11 with bevel pointing upward. CSF outflow from the 
incised dura confirmed the correct location, and the proximal 
tip of the syringopleural shunt was placed through the dural 
incision using a CODMAN™ lumboperitoneal catheter, 
JAMES™ design (internal diameter 0.76  mm; external di-
ameter 1.65  mm), inserted at the level of the C3 and in a 
cranial direction. The presence of CSF flowing through the 
distal catheter tip ensured its correct placement and function-
ality. Pressure was controlled through distal slit valves (5-
9cm H2O medium pressure), four slits 90° apart. The incised 
dura was anchored over the shunt catheter using single inter-
rupted 6-0 Vicryl™ (Ethicon™) absorbable braided suture, 
the proximal catheter was subsequently looped three times 
and at each bend, and purse-string sutures were applied using 
a synthetic, monofilament, nonabsorbable polypropylene su-
ture (Prolene™ 5-0) to anchor the catheter to the surrounding 
epaxial muscles. The dural incision did not need further clo-
sure, as no CSF leakage was present around the shunt cath-
eter. An absorbable collagen fleece (Lyostypt™) was placed 
over the laminectomy site. The distal tip of the shunt catheter 
was inserted subcutaneously and passed tangentially across 
the intercostal muscles into the pleural space at the left ninth 
intercostal space. Two concentric nonabsorbable polypro-
pylene pursue-string sutures (Prolene™ 5-0) were applied 
anchoring the tube to the intercostal muscles. The ends of 
the sutures were used to perform a "Chinese-finger trap" su-
ture around the distal catheter. Skin closure was performed 
using a nonabsorbable monofilament (Ethilon™ 3-0) single 
interrupted cruciate sutures. Postoperative CT confirmed 
the correct placement of the shunt and the resolution of the 
CSF-filled structure. Over the following 2  months, the pa-
tient continued the physiotherapy and showed a progressive 
neurological amelioration, although a mild ataxia, thoracic 
limb hypermetria, and right-sided paresis persisted. Despite 
F I G U R E  2  Magnetic resonance 
images; mid-sagittal 3D-CISS (A and D) 
and transverse 3D-CISS (B, C, E, F) images 
at the level of the C2-C3 intervertebral disc 
space showing the laminectomy site (blue 
dashed line and arrow) and syringomyelia 
(SM) (pink dashed line and arrow) at 2m 
(A, B, C) and 6m (D, E, F) postsurgery to 
address SAD
(A) (B) (C)
(D) (E) (F)
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several attempting in reducing the dosage, prednisolone was 
continued as previously stated (Table 1).
Three months after shunting, the dog was re-examined 
due to an acute collapse episode. CT was performed and 
showed the resolution of both SAD and SM; however, the 
distal tip of the shunt catheter was displaced and coiled sub-
cutaneously at the level of its insertion into the pleural space. 
Revision surgery was performed, and the shunt catheter was 
re-inserted into the pleural space. The patency of the catheter 
was confirmed intra-operatively with the presence of CSF-
like fluid flow at the distal tip. Postoperative CT was per-
formed to confirm the correct shunt placement.
At 1-month re-examination, the dog's neurological status 
was unchanged and continued to show mild ataxia and right-
sided paresis with the tendency to stumble on his thoracic 
limbs; prednisolone was continued. Hydrotherapy and a quad 
wheelchair for dogs (Walkin' Wheels®) were provided to sup-
port his recovery.
The dog slowly improved and 6 months after shunt place-
ment, MRI was performed: Shunt catheters were in situ, SAD 
and SM appeared to be resolved, and the spinal cord edema 
was mild being only present dorsally at the level of C4 ver-
tebra. It was noted the recurrence of the SAD on the right 
side and cranially to the surgical site; however, this was con-
sidered minimal and future monitoring was recommended 
(Figure 3).
The dog continued to improve, and prednisolone was 
gradually tapered down over 3-month period to 0.15 mg/
Kg every other day. An update from the owner was obtained 
2 years after shunt surgery: Prednisolone was tapered with 
no further neurological deterioration. Ambulation had 
greatly improved postshunt surgery, displaying only sub-
tle ataxia and hypermetria referable to his thoracic limbs 
(Video S2). Episodes of face rubbing against a pillow and 
licking at his right back paw, without the presence of any 
skin disease, were subsequently reported. Due to finan-
cial constraints, further imaging (even with 80% discount) 
could not be pursued. Hydrotherapy was restarted, and the 
signs appeared to subside. No further medical treatment 
was necessary.
3 |  DISCUSSION
The recognition and diagnosis of SAD associated with SM 
are increasing in veterinary medicine.4-9
Spinal arachnoid diverticulum is developmental or ac-
quired intradural-extramedullary cavities filled with CSF, 
causing focal compression of the spinal cord parenchyma 
with secondary myelopathy.5 SM is a well-defined discrete 
cavity within the spinal cord that contains fluid that is iden-
tical or similar to CSF.10 However, the exact pathogenesis of 
these lesions remains still unknown,9,11 but it is associated 
with CSF channel obstruction and in particular Chiari-like 
malformation (CM).6,12,13
Although our case had other intracranial congenital or 
developmental malformations such as ventriculomegaly and 
supracollicular fluid accumulation, CM or other craniocer-
vical junction abnormalities typically associated with SM 
and SAD 6,9 were not present. Furthermore, no infection or 
F I G U R E  3  Magnetic resonance 
images; para-sagittal 3D-CISS (A) and 
transverse (B and C) images at the level 
of the C2-C3 intervertebral disc space 
showing a newly formed spinal arachnoid 
diverticulum (SAD) (blue dashed line and 
arrow) on the right side and cranially to the 
previous surgical site, while the proximal tip 
of the shunt catheter remained at the correct 
location (pink dashed line and arrow) with 
the resolution of the previously diagnosed 
SM and SAD
(A)
(B) (C)
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previous trauma was reported. This would suggest that the 
dog's neurological signs associated with partial obstruction 
of the CSF flow were due to a developmental SAD, causing 
spinal cord compression and secondary edema especially as 
the SM was immediate caudal to the SAD. In addition, the 
reported hyperaesthesia such as face rubbing could be asso-
ciated with the cervical spinal lesions and greater occipital 
nerve root irritation (ie, dorsal branch of the second cervical 
nerve), which is a renowned nerve associated with facial neu-
ralgia.14 This appeared to respond to gabapentin which is a 
drug commonly used to treat neuropathic pain.15
Syringomyelia was initially considered to be secondary to 
SAD, due to changes in temporal CSF pulse pressure dynam-
ics.6,7,9,11,13,16-18 Therefore, the surgical treatment of SAD via 
durotomy and marsupialization was considered sufficient to 
re-establish normal CSF flow with resolution of SM. Although 
marsupialization is recommended because of the apparent trend 
toward a better outcome,5 in our case, the resolution of the SM 
did not occur following surgery. Furthermore, a newly SAD 
was identified caudal to the previous surgical site and dorsal 
to SM, with concurrent and progressive signs of CSF disrup-
tion and secondary spinal cord edema (Table 1). We therefore 
opted to use a shunt procedure to treat both conditions. This 
belt and braces approach was considered safer than another 
marsupialization and then another surgery to address SM, if 
that failed. Shunt surgery has been suggested to be beneficial 
to treat SM,5,13 SAD,6,19 and recurrent SAD 20 or to increase 
the success rate when an adequate result has not been obtained 
otherwise.18 The cause of SAD recurrence at a more caudal lo-
cation would suggest the formation of postoperative arachnoid 
adhesions. Addressing the newly formed CSF-filled structure 
with another marsupialization could have led to the creation 
of other CSF-filled structures due to the inevitable scar forma-
tion, with SM remaining untreated. However, SAD recurrence 
could have also been related to the natural progression of the 
disease. The use of a syringopleural shunt in our case appeared 
more indicated, and it led to the resolution of both SAD and 
SM. We opted to shunt into the pleural space rather than perito-
neal space, due to the limitation in length of the shunt catheter 
after purse-string sutures were applied. A syringosubarachnoid 
or subarachnoid-subarachnoid shunt placement was not per-
formed, due to the lack of adequate catheter size for the SM size 
and subarachnoid space available. Moreover, syringopleural 
shunting would be considered usual practice in humans, as the 
negative pressure of the intrathoracic cavity appears to be ef-
fective for draining syrinx fluid.21 Major complications related 
to shunt placement in dogs are shunt obstruction, pain, shunt 
infection, catheter migration, and kinking.22,23
The shunt catheters used in the previous reports were 
from either a ventriculoperitoneal shunt kit,13,19 Kendall red 
rubber latex urethral catheter,19 equine ocular lavage silicone 
catheter,6 or Silastic™ tube.5 Previous studies reported a 
subarachnoid-subarachnoid shunt placement to treat SAD,19 
a syringosubarachnoid shunt placement to treat SM,6,13 and 
a syrinx to the cisterna magna shunt placement to treat SM 
concurrent to SAD.5 In Motta and others (2012), the shunt 
catheter was not secured to the meningeal layer. In these pre-
vious reports, the lack of follow-up imaging was the major 
limitation: Only in Motta and others (2012), 3/11 dogs had 
postsurgical MRI (immediately postoperatively in 1 dog, four 
weeks after surgery in 1 dog, and six weeks after surgery in 
1 dog), while the long-term follow-ups were otherwise based 
on owner's update (via telephone conversations or videos) or 
physical examination in the others.
In our study, we have performed postoperative imaging up 
to 1y 2m from the marsupialization and 6m from the shunt 
placement. Neurologic examinations, telephone, and email up-
dates were obtained up to 2y8m from the marsupialization and 
2y from the shunt placement (Table 1). We were able to verify 
the correct shunt catheter placement, address complications 
(such as due to shunt catheter displacement), and monitor the 
disease progress. We have also used a dedicated spinal shunt 
catheter to divert CSF from the SAD and SM to the pleural 
space, contrary to the previous reports.5,6,13,19 Contrary to the 
other studies,7,11,16,19,20 SM did not resolve following surgery 
to address SAD, but did resolve following syringopleural shunt 
surgery and allowed the discontinuation of prednisolone ther-
apy (Table 1). The use of quad wheelchair may have further 
assisted the dog's rehabilitation and supported his recovery.
Despite the efforts in obtaining postoperative imaging, 
financial constraints did not allow us to repeat advanced im-
aging evaluation in the most recent follow-ups. This remains 
the major limitation of this study. Hence, we could not further 
assess the progression of the newly formed SAD.
Finally, the results of our study suggested that marsupi-
alization of SAD did not resolve SM and both conditions 
needed to be addressed. The placement of a syringopleural 
shunt allowed us to address both conditions and improve 
the neurological status allowing discontinuation of cortico-
steroid therapy. The use of quad wheelchair for dogs can be 
beneficial to provide further support during postoperative re-
habilitation. This study also showed that repeating imaging 
is essential to confirm the resolution of SAD and SM, the 
correct shunt placement, identify the reason for neurological 
deterioration, and choose the most appropriate intervention 
for our patients.
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